 "Thyrocare files draft IPO papers")
Diagnostic company Thyrocare Technologies Ltd said on Thursday it had filed draft red herring prospectus with the country's market regulator for an initial public offering (IPO) of 10.7 million shares.
Thyrocare said it plans to list on both the BSE and NSE exchanges. JM Financial, Edelweiss Financial, ICICI Securities are lead managers for the issue.
Reuters reported in February Thyrocare was planning to raise $85 million to $100 million through a stock market listing, citing two sources familiar with the matter.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app